54
Participants
Start Date
January 31, 2012
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
Pregabalin
Subjects are randomized 1:1 to either pregabalin treatment or placebo. The intervention period is 8 weeks. The daily pregabalin dose is 75 mg. during the first week followed by 7 weeks of flexible daily dosing (150, 300, 450 or 600 mg.) depending on tolerability and response. Doses above 150 mg. should be divided in two daily dosages.
Pregabalin Placebo Capsules
Parallel to Active Comparator
Aalborg University Hospital, Psychiatry, Aalborg
Collaborators (1)
Albert Einstein College of Medicine
OTHER
GCP-unit at Aarhus University Hospital, Aarhus, Denmark
OTHER
The Hospital Pharmcacy North Denmark Region, Denmark
UNKNOWN
Pfizer
INDUSTRY
University of Aarhus
OTHER